Welcome to Awesome Blog Design perfect blog
Business, Social Media & Tech.

 Onyx Enterprises Int’l, Corp. and Legacy Acquisition Corp. to participate in SPACInsider-ICR webinar on October 22nd at 2pm ET

 NEW YORK & CRANBURY, N.J.–(BUSINESS WIRE)–Onyx Enterprises Int’l, Corp. (“Onyx”), owner and operator of a leading digital commerce platform for the automotive market, “CARiD.com,” which has entered into a definitive business combination agreement with Legacy Acquisition Corp. (NYSE: “LGC”) (“Legacy”), a publicly-traded

Business, Healthcare

OPTIMIZE study reports lowest TLR ever achieved in an Investigational Device Exemption (IDE) study with Svelte Medical System’s bioresorbable coated drug-eluting coronary stent

OPTIMIZE Pivotal Study 1 Year Outcomes Announced at TCT Connect NEW PROVIDENCE, N.J.–(BUSINESS WIRE)–The Svelte® Drug-Eluting Stent (DES) achieved 1.5% clinically-driven Target Lesion Revascularization (TLR) at 1 year, the lowest ever reported in an Investigational Device Exemption (IDE) clinical study. Primary and

Business, Healthcare

Bristol Myers Squibb receives positive CHMP opinion recommending Opdivo (nivolumab) as second-line treatment for unresectable advanced, recurrent or metastatic esophageal squamous cell carcinoma

Application based on Phase 3 ATTRACTION-3 trial demonstrating a statistically significant and clinically meaningful improvement in patients’ overall survival compared to chemotherapy PRINCETON, N.J.–(BUSINESS WIRE)–$BMY #ATTRACTION3—Bristol Myers Squibb (NYSE:BMY) today announced that the Committee for Medicinal Products for Human Use (CHMP) of

Business, Healthcare

LabCorp and HealthEC launch transformative oncology care module

New Software Tool Designed to Help Oncologists Improve Patient Outcomes and Achieve Cost-Saving Goals Available Exclusively through LabCorp and Powered by HealthEC® BURLINGTON, N.C. & EDISON, N.J.–(BUSINESS WIRE)–LabCorp (NYSE: LH), a leading global life sciences company that is focused on advancing health